Skip to main content

IHI project spotlight: PharmaLedger

The event is part of a series of live sessions that IHI is organising on IMI projects, where project participants demonstrate how their project contributed to addressing key challenges in health research and innovation.

Heung Soon via Pixabay



About PharmaLedger

Blockchain technology is best known for its use in the Bitcoin currency, but it has the potential to revolutionise other industries as well.


PharmaLedger aimed to create a blockchain platform in healthcare that is supported and trusted by various stakeholders, and compliant with laws and regulations. To achieve this, the project brought together experts in technology, law, and regulation, as well as representatives from pharmaceutical companies and patient organisations.


The project aimed to demonstrate the value of its system through a number of use cases, including: 

•    electronic Product Information (ePI)
•    Clinical Trial eConsent
•    Falsified Medicines Detection
•    Clinical Trial eRecruitment
•    Tracking Clinical Supply
•    Finished Goods Traceability
•    Medical Device Internet of Things


Ultimately, the project hopes that its outputs will provide a widely trusted digital trust ecosystem that supports the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that benefits the entire ecosystem, from manufacturers to patients.  


During this event, project representatives presented two use cases as well as the PharmaLedger Association, which will carry on the project’s legacy.


PharmaLedger is supported by the Innovative Medicines Initiative, a partnership between the European Union and the European pharmaceutical industry.


Session Recording and Presentations




You can download the presentations here.




14:00 - 14:10 - Introduction to the PharmaLedger project

14:10 - 14:35 - Use case 1: electronic Product Information (ePI)
                         Presentation followed by Q&A


14:35 - 15:00 - Use case 2: electronic Consent (eConsent) for clinical trials
                         Presentation followed by Q&A


15:00 - 15:20 - Next steps: PharmaLedger Association

15:20 - 15:30 - Closing remarks




Meet the speakers
Maria Eugenia (Xenia) Beltran

 Head of Big Data LifeSTech & PharmaLedger Project Coordinator

Universidad Politécnica De Madrid

Marco Cuomo

Director Tech Products & Innovation


Daniel Fritz

Executive Director

PharmaLedger Association

Colm Carroll

Scientific Project Manager, IHI

Event Moderator